As teams become empowered to work from anywhere in the world, it is necessary for all stakeholders in a trial to have readily available access to information on the clinical trial in real-time.
FREMONT, CA: The number of industries shifting to virtual and remote operations is rapidly increasing, and the realm of clinical trials is no different. The offset of the COVID-19 pandemic has only accelerated the industry’s dependence on technology to efficiently and successfully run trials. This shift has prompted the field to accept virtual or decentralized clinical trials as a trusted means to research such vital importance. As teams become empowered to work from anywhere in the world, it is necessary for all stakeholders in a trial to have readily available access to information on the clinical trial in real-time. With the right tools and technology to navigate a decentralized clinical trial, it is possible to ensure a positive outcome for the sponsors, and more importantly, an accelerated timeline for patients to gain access to life-changing medicines.
Study Startup Management Systems (SSMS) are an essential tool to accelerate clinical trial start-up efficiently. From all steps throughout the start-up process beginning with targeting the right sites, assessing site interest, conducting feasibility, collecting essential regulatory documents, obtaining approvals and contracts, and finally, enrolling patients, an SSMS ensures that a trial launches on-time and with the optimal sites.
Every SSMS includes a built-in database of investors to deliver the optimal sites. It runs on an automated workflow, enabling sponsors to quickly move from task to task and ensure that the start-up is progressing with no hold-ups. An SSMS’ cloud-based nature provides readily available access to data, metrics, and reporting anytime and anywhere. “AcceleTrialTM identifies sites based on objective data validating therapeutic expertise, clinical trial experience, and access to patients that provides transparency for sponsors in choosing the right site. This model takes the guesswork out of clinical trial site identification and combined with an automated workflow, accelerates clinical trial start-up,” says Kathleen Colatrella, Founder and President at LINEA Systems.
AcceleTrial was created by LINEA Systems, with the founding principle that nearly all clinical trials can avoid delays by selecting the right sites initially. The company has a database of over 10,000 global expert investigators, who are all ranked objectively. AcceleTrial™’s proprietary algorithm pulls over 1,000 data points from multiple sources based on clinical expertise, access to patients, and previous clinical trial experience, among other metrics. This powerful ranking system ensures that ultimately, the most effective and optimal investigators and sites are selected for the trial, thereby mitigating any chance of delay.
LINEA Systems was listed as one of the Top eClinical Trial Management Solution Providers for 2020 by MD Tech Review Magazine. The company’s push and pull workflow ensures a steady momentum, tracking each step and keeping the process seamless. To add transparency, both the sponsor and the sites and investigators can access the platform and complete their respective tasks while monitoring the full scope of the process.